Clinical Trial Update: Intravitreal Bevacizumab for Polypoidal Choroidal Vasculopathy [NA]

View source ↗

Summary

Clinical trial update on intravitreal bevacizumab for polypoidal choroidal vasculopathy; the current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polypoidal Choroidal Vasculopathy

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Asan Medical Center | Conditions: Polypoidal Choroidal Vasculopathy | NA | Status: UNKNOWN